scorecardresearch
Add as a preferred source on Google
Wednesday, November 5, 2025
TopicSerum Institute of India

Topic: Serum Institute of India

US embargo on exporting Covid vaccine raw materials and how it could impact India

US decision to prioritise domestic demand is why certain raw materials — which are manufactured in US or whose parent firms are based there — are not available for India.

Early orders, more funds, swift payments — govt panel tips for boosting India’s vaccine supply

According to report by inter-ministerial panel, Bharat Biotech could double its production capacity soon while Serum Institute of India is still looking for ways to expand production.

How India’s second wave is slowing Covid vaccine delivery to Africa

Most African nations are dependent on Covax facility for vaccines. Covax is reliant on AstraZeneca’s shot & leans on Serum Institute to manufacture its allotments.

Prioritise Covid vaccine supplies within India over exports, govt tells Serum & Bharat Biotech

Health ministry officials say there is no ban on exports but govt is expanding the vaccination drive for which India needs more vaccines for domestic consumption. 

UK’s Covid vaccine shortage blamed on delay in shipment from India’s Serum Institute

The supply crunch prompted the UK government to shift focus & offer remaining doses to people most at risk of developing severe forms of Covid-19.

Covid vaccine nationalism is threatening WHO’s 2021 goal of 2 bn doses, Adar Poonawalla says

The Serum Institute of India CEO reiterated concerns over impending bottlenecks caused by 'raw materials nationalism' after the US invoked an act to safeguard supplies.

Delhi HC asks Serum Institute, Bharat Biotech to reveal Covid vaccine manufacturing capacity

The high court also asked the Centre to explain in affidavit the rationale behind keeping strict control over class of persons who can be vaccinated against Covid.

Many trial participants still unsure about vaccine or placebo status, SII info only on request

As India rolls out its second phase of immunisation, Covid trial participants are seeking information about their status. But govt has allowed only individual requests.

China, Russia & North Korea hackers target AIIMS, SII, Patanjali for Covid data — report

Report by cyber intelligence firm Cyfirma says threats to global healthcare firms were noticed in February, hackers targeted those investing in medical research, clinical trials, vaccine production.

Fire at Serum institute that killed 5 erupted due to short circuit, says Ajit Pawar

The premises where the blaze erupted was empty, It is a private institute and they are carrying out their audit. The govt is also investigating, Maharashtra Deputy CM added.

On Camera

Indians have a complicated relationship with Zohran Mamdani

Mamdani’s politics feels unusual compared to India’s current climate. He unapologetically foregrounds Muslim identity at a time when doing so in India invites scrutiny.

What does NCLAT order mean for data-sharing ban, penalty imposed by CCI on Meta & WhatsApp

On 4 November 2025, NCLAT bench, comprising Chairperson Justice Ashok Bhushan and Member Arun Baroka, noted that WhatsApp and Meta are distinct legal entities.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.